Thus, although no strong evidence that proteins other than SFRP1 were epigenetic therapy targets for NSCLC was obtained, it is likely that other proteins identified in this study are epigenetic therapy targets. The gene discussed is SFRP1; the disease is non-small cell lung carcinoma.